Malvern adds new applications to market-leading GPC/SEC system
Publication date: 4 May 2010
Author:
Tagged with: Malvern Instruments
Malvern Instruments has extended the applications for its Viscotek Triple Detector Array (TDA), the multi-detector platform for gel permeation/size exclusion chromatography (GPC/SEC), through the inclusion of a new viscometer in the setup. The TDA maximises the productivity of GPC/SEC analysis by simultaneously measuring absolute molecular weight, molecular size and intrinsic viscosity. The new viscometer combines unrivalled sensitivity with an innovative 316 stainless steel transducer construction that offers excellent chemical resistance. It therefore provides the most precise intrinsic viscosity and structural information for an expanded range of biomolecules, natural and synthetic polymers.
The unique viscometer design uses digital inert transducer technology to give a faster, more sensitive response to viscosity changes than traditional transducers. Its 316 stainless steel construction means that there are now few limitations, in terms of salt content or pH, on the chromatographic conditions that can be used. This is a significant benefit for protein analysis. The use of inert capillaries in the measuring flow path is also advantageous for many biomolecule applications.
The TDA lies at the heart of the Viscotek TDAmax: a complete, advanced GPC/SEC system suitable for all macromolecular applications. However, each element of the TDA can be purchased alone or in combination, offering exceptional flexibility to those with existing GPC/SEC systems. UV and/or PDA detectors are also available to further augment detection capabilities. These are especially useful for the analysis of composition for copolymers and/or conjugated proteins.
http://www.malvern.com/viscotek_tdamax
Malvern and Malvern Instruments are registered trademarks of Malvern Instruments Ltd
Advertisement:
Email newsletter
If you enjoyed this article sign-up to receive our bi-weekly email newsletter:
Latest news
- Novartis NVA237 Phase III data showed rapid, sustained improvement in lung function and symptom relief over one year in COPD patients (17 May 2012)
- Amgen’s BiTE® Antibody Blinatumomab achieved high rate of complete response in adult patients with relapsed or refractory acute lymphoblastic leukemia (16 May 2012)
- GlaxoSmithKline completes transaction to increase its ownership in Theravance (16 May 2012)
- Catalent announces winners of Global Academic Competition for Life Science Leaders of Tomorrow (16 May 2012)
- Roche will report new data on important progress for people with advanced cancers at ASCO 2012 (16 May 2012)
In-depth focus:
Mass Spectrometry
This free to view Mass Spectrometry in-depth focus is sponsored by Waters, Bruker, Protea and Dr. Hochmuth and contains the following articles:
- Mass spectrometry in drug discovery - Proteomics, small molecules and metablomics
- Quantification of membrane drug transporters and application in drug discovery and development
- Anthony Bristow, AstraZeneca, poses the questions for our Mass Spectrometry Leaders Roundtable
Company directory
ABB Analytical Measurements | Almac | B&W Tek, Inc. | BASF | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Optics | CAMO Software AS | Catalent Pharma Solutions | Chemspec Europe Ltd | CI Precision | Cisbio Bioassays | EMD Millipore | GE Analytical Instruments | Gerresheimer Group | HACH LANGE GMBH | HORIBA Scientific | I Holland Limited | Lonza | Merck Millipore | Pall Life Sciences | Patheon Inc | Phenomenex | Porvair Sciences Ltd | Randox Pharma Services | Rapid Micro Biosystems | Realia | Roche | rommelag® | Umetrics |
Login to access exclusive content